Clinical & Experimental Cardiology
Open Access

Nilofer Qureshi

Publications

• Research Article
  Nutritional Supplement-5 with a Combination of Proteasome Inhibitors (Resveratrol, Quercetin, δ-Tocotrienol) Modulate Age-Associated Biomarkers and Cardiovascular Lipid Parameters in Human Subjects
  Author(s): Asaf A. Qureshi, Dilshad A. Khan, Wajiha Mahjabeen, Christopher J. Papasian and Nilofer QureshiAsaf A. Qureshi, Dilshad A. Khan, Wajiha Mahjabeen, Christopher J. Papasian and Nilofer Qureshi
  
  Background: Age-associated altered redox imbalances and dysregulated immune function, contribute to the development of a variety of age associated diseases. Inflammatory markers and lipid profiles are useful prognostic indicators of a variety of age-associated and cardiovascular diseases. We have previously studied the impact of several proteasome inhibitors on several markers of inflammation and lipid profiles in-vitro, in vivo, in cell lines, animal models, and in human subjects. The current study represents an extension of this work. Our main hypothesis is that a combination of various naturally-occurring proteasome inhibitors, which inhibits nitric oxide (NO), and C-reactive protein (CRP) mediated inflammation, will have better efficacy in the prevention and treatment of ageassociated disorder including cardiovascular disease... View More»
  DOI: 10.4172/2155-9880.1000238

  Abstract PDF

Relevant Topics